Understanding how cells manage misfolded proteins at their membranes
Protein quality control at eukaryotic membranes
This study is looking at how cells find and get rid of damaged proteins to keep themselves healthy, which could help us understand how our bodies respond to stress and fight off infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11136857 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which cells identify and degrade misfolded proteins within their membranes, focusing on a process known as Endoplasmic Reticulum-associated degradation (ERAD). By examining how proteins are selected for degradation and how they are transported across the membrane, the study aims to uncover the cellular pathways involved in maintaining protein quality. The research employs a combination of genetic, biochemical, and structural techniques to explore these processes in detail, which could enhance our understanding of cellular stress responses and pathogen interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions associated with protein misfolding or cellular stress responses.
Not a fit: Patients with conditions unrelated to protein quality control or those not experiencing cellular stress may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases related to protein misfolding, such as neurodegenerative disorders.
How similar studies have performed: Previous research has shown promising results in understanding protein degradation mechanisms, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Baldridge, Ryan Douglas — University of Michigan at Ann Arbor
- Study coordinator: Baldridge, Ryan Douglas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.